about
Evaluation of SCH51048 in an experimental model of pulmonary aspergillosisEfficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosisIn vitro activity of a new oral triazole, BMS-207147 (ER-30346)Aspergillus fumigatus and aspergillosisHistory of medical mycology in the united states.Phaeohyphomycosis from Exphiala jeanselmei with concomitant Nocardia asteroides infection in a renal transplant recipient: case report and review of the literature.Aspergillus mastoiditis in a patient with systemic lupus erythematosus: a case reportPractice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosisRegulatory circuitry governing fungal development, drug resistance, and disease.Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies.Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.Itraconazole--perspectives for the management of invasive aspergillosis.Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.Itraconazole resistance in Aspergillus fumigatusIn vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosisIn vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agentEvaluation of the Double Agar Gel Immunodiffusion Test and of the Enzyme-Linked Immunosorbent Assay in the Diagnosis and Follow-Up of Patients with Chronic Pulmonary Aspergillosis.In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi.Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.Effect of cyclodextrin on the pharmacology of antifungal oral azoles.Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.Recent developments in pradimicin-benanomicin and triazole antibiotics.Clinical pharmacology of antifungal agents in pediatric patients.Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and reviewPotent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazolePulmonary considerations of organ transplantation. Part 3.Antifungal therapeutic drug monitoring: established and emerging indications.Fungal malignant otitis externa with facial nerve palsy: tissue biopsy AIDS diagnosis.Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics.Current concepts in antifungal pharmacology.Pulmonary infectious complications of human immunodeficiency virus infection. Part II.Combination therapy in systemic mycosis.Itraconazole: Precautions regarding drug interactions and bioavailability.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Treatment of aspergillosis with itraconazole.Aspergillus Biofilms in Human Disease.Oral voriconazole for invasive fungal skull base infection.Management of pulmonary aspergillosis in AIDS: an emerging clinical problem
P2860
Q28367767-B3EC814B-F264-4C74-A8E9-77142304B6BFQ28379262-0AF50CA3-1538-41A5-8BE0-FAA3A5798079Q28379428-4314A64E-22D4-4008-97C0-1E33F42AC058Q29617908-07CB7EA7-E61C-4230-B99C-880BED5B0ACBQ30452877-8923F56A-C521-42F8-9DAC-1E77D94CC2B7Q33715935-BECB35BA-123D-45CB-B57C-C55BFC617574Q33854124-BED689C0-76D6-40F7-84A6-DEBDFEABD418Q33894472-BC1CF947-4F8C-45AC-9F22-A74CE48590B7Q34111556-5EC358FC-509E-441A-903A-0B793F5876C0Q34190284-8695BBD0-1ADF-4A6D-B99C-71E1287A3852Q34330077-ABD89364-0DB6-4BE1-AA92-BA67923E1256Q34428225-018BC448-B0ED-4438-8D7F-3FC650325BE2Q35105394-107ADBBF-82E3-4E71-BDCF-400881229CDBQ35117396-3E251E61-DC63-498A-B257-A9A8F2471F73Q35136791-1277A0A1-9190-48FE-8AFD-3CA46EAB381AQ35138343-B48830DA-4490-48DC-AABD-B3481418ABA2Q35257842-E5B32042-D78B-4B47-BB96-5ACB4B1062F7Q35745180-63BFBA8E-7C4D-46DC-AA97-D70708E76CF5Q35776187-FE2D36DF-80FB-4971-8772-D5F7E63501D7Q35821534-AAD6D404-2796-4795-8504-F2B491B2B2A7Q35826467-F348405E-D6ED-4B04-AED7-6A38D3E6BF83Q35904922-C86CCAFC-87F8-4DD6-8332-2936E056F83BQ36179732-1099CF45-7C7B-489D-9C1F-D62DBABC0EFBQ36968140-0967A25D-80DC-4518-AE7B-7CD584BA8299Q37115777-0C139EF7-ABD7-4428-9BAD-0D58F4708E50Q37119654-EC65B06F-46C0-44B7-91BD-6E3F4CE4DDDFQ37203447-00AD8BC7-7CCC-47F9-8DCF-57BF402D70E5Q37310029-486C0D9E-7787-496E-96D2-2A699B4CB60FQ37600606-8F33ED9C-C468-495A-8F3E-7AFD1C1CAC1EQ37688257-E2BF99B2-A844-4A5F-9DFF-406F183F2D9AQ37904672-2634899B-57E8-4CCB-B437-99D9BF9ED03CQ37908856-45F27255-4C73-4D90-A38C-D9C202468EDDQ37929672-ADA4EB69-9871-4567-81CF-B1DFE3D7938AQ37981693-352BC728-21CA-4790-9AB6-609FCFD603D4Q37985918-AB7AEEB3-2F98-457E-BA85-6ABFD54423A6Q38193337-0B05CBB4-DF22-4034-A285-20D4B930115BQ38567823-AB360FB7-2F1D-4025-B983-673D34677548Q38857862-10401B2D-12C3-43DE-ABAF-B1A9F03B2A15Q39340573-D13FD473-40AC-4950-8410-E9748FE3309BQ39394767-E3065D7D-1080-441A-AF72-A6C5DF4571E2
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Treatment of invasive aspergillosis with itraconazole.
@en
Treatment of invasive aspergillosis with itraconazole.
@nl
type
label
Treatment of invasive aspergillosis with itraconazole.
@en
Treatment of invasive aspergillosis with itraconazole.
@nl
prefLabel
Treatment of invasive aspergillosis with itraconazole.
@en
Treatment of invasive aspergillosis with itraconazole.
@nl
P2093
P1476
Treatment of invasive aspergillosis with itraconazole.
@en
P2093
D A Stevens
L H Hanson
R M Tucker
P304
P356
10.1016/0002-9343(89)90475-0
P407
P433
P577
1989-06-01T00:00:00Z